DocMorris AG (SWX:DOCM)
Switzerland · Delayed Price · Currency is CHF 5.01
+0.04 (0.80%)
Apr 2, 2026, 5:30 PM CET
DocMorris AG Revenue
In the year 2025, DocMorris AG had annual revenue of 1.12B CHF with 10.56% growth. DocMorris AG had revenue of 291.49M in the quarter ending December 31, 2025, with 11.95% growth.
Revenue
1.12B
Revenue Growth
+10.56%
P/S Ratio
0.21
Revenue / Employee
841.03K
Employees
1,576
Market Cap
239.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12B | 107.41M | 10.56% |
| Dec 31, 2024 | 1.02B | 47.58M | 4.91% |
| Dec 31, 2023 | 969.46M | 38.49M | 4.13% |
| Dec 31, 2022 | 930.97M | -795.53M | -46.08% |
| Dec 31, 2021 | 1.73B | 249.57M | 16.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| Ascom Holding AG | 292.10M |
| COLTENE Holding AG | 240.05M |
| IVF Hartmann Holding AG | 161.85M |
| Santhera Pharmaceuticals Holding AG | 49.02M |
DocMorris AG News
- 2 years ago - Online drug retailer DocMorris meets expectations as cost savings help - Reuters
- 2 years ago - Online drug retailer DocMorris trims top end of 2023 outlook - Reuters